Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients

BackgroundMetastatic breast cancer (mBC) is a heterogeneous disease with varying responses to treatments and clinical outcomes, still requiring the identification of reliable predictive biomarkers. In this context, liquid biopsy has emerged as a powerful tool to assess in real-time the evolving land...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Elena Muraro, Fabio Del Ben, Matteo Turetta, Daniela Cesselli, Michela Bulfoni, Rita Zamarchi, Elisabetta Rossi, Simon Spazzapan, Riccardo Dolcetti, Agostino Steffan, Giulia Brisotto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
coleção:	Frontiers in Oncology
Assuntos:	metastatic breast cancer (mbc) liquid biopsy circulating tumor cells (CTCs) anti-tumor T-cells T-cell receptor (TCR)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.983887/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!